Mirae Asset Global ETFs Holdings’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77.4K Sell
31,852
-630
-2% -$1.54K ﹤0.01% 2929
2026
Q1
$77K Buy
32,482
+782
+2% +$2.71K ﹤0.01% 2783
2025
Q4
$164K Buy
31,700
+513
+2% +$2.49K ﹤0.01% 2441
2025
Q3
$132K Sell
31,187
-6,194
-17% -$28.8K ﹤0.01% 2541
2025
Q2
$137K Sell
37,381
-4,909
-12% -$18.3K ﹤0.01% 2450
2025
Q1
$183K Buy
42,290
+658
+2% +$2.66K ﹤0.01% 2372
2024
Q4
$133K Buy
41,632
+1,783
+4% +$5.98K ﹤0.01% 2581
2024
Q3
$114K Buy
39,849
+4,055
+11% +$11.4K ﹤0.01% 2655
2024
Q2
$100K Buy
+35,794
New +$96.1K ﹤0.01% 2562

Other funds holding ORGO

Mirae Asset Global ETFs Holdings's ORGO Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Organogenesis Holdings (ORGO) stake by 1.9% in Q2 2026, selling an estimated $1.54K and leaving 31,852 shares worth $77.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2929.

Mirae Asset Global ETFs Holdings first reported a position in ORGO in Q2 2024 and has held it in 9 quarters since. The position peaked at $183K in Q1 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 31,852 shares of Organogenesis Holdings worth $77.4K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 630 Organogenesis Holdings shares in Q2 2026, an estimated $1.54K.
  • Organogenesis Holdings made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2929 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Organogenesis Holdings in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Organogenesis Holdings position peaked at $183K in Q1 2025.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.